A Day Up For Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc. (ARMP:NYSEMKT) shot up at $4.84, representing a gain of 23.5%. On Fri, Nov 19, 2021, ARMP:NYSEMKT touched a New 2-Week Intraday High of $4. The stock appeared on our News Catalysts scanner on Thu, Nov 18, 2021 at 10:17 AM in the 'BIOTECH' category. From Fri, Nov 05, 2021, the stock recorded 60.00% Up Days and 72.73% Green Days

About Armata Pharmaceuticals Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.